Patents for C12R 1 - Micro-organisms (92,025) |
---|
05/29/1991 | EP0429209A1 New antibiotic chemical compound "DC 114-C" |
05/29/1991 | EP0429093A2 Transformation of plant genotype |
05/29/1991 | EP0428615A1 Method for stabilizing heterologous protein expression and vectors for use therein |
05/29/1991 | EP0248832B1 Method for cultivating microorganisms, particularly of the frankia group and preparation of bacterial inoculums |
05/29/1991 | EP0229161B1 Composite plasmids for amino acid synthesis |
05/29/1991 | DE3938971A1 Leukozytenelastase und kathepsin g blockierendes peptid, dna, vektor, wirtsorganismus und verfahren zu seiner gewinnung sowie pharmazeutisches praeparat Leukocyte elastase and cathepsin G-blocking peptide, dna, vector, host organism and proceed to its recovery as well as pharmaceutical of preparation |
05/29/1991 | CN1051757A Polypeptide compound and process for preparation thereof |
05/29/1991 | CA2030929A1 Bacterial collagenase gene |
05/29/1991 | CA2030912A1 Dna-sequence conferring resistance to the antibiotic thermorubin |
05/29/1991 | CA2029249A1 Method for the fermentative production of diacetyl and acetoin using lactic acid bacterium |
05/28/1991 | WO1991008300A1 Process for the preparation of vancomycin |
05/28/1991 | US5019648 Monoclonal antibody specific for the adhesion function domain of a phagocyte cell surface protein |
05/28/1991 | US5019593 Antifungal fermentation products and compositions thereof |
05/28/1991 | US5019514 Aureobasidium pullulans strain, process for its preparation, and use thereof |
05/28/1991 | US5019507 Novel cyclomaltodextrin glucanotransferase |
05/28/1991 | US5019505 Enzymes having alpha-glycerol-3-phosphate oxidase activity, production and use thereof |
05/28/1991 | US5019503 Method for production of l-threonine |
05/28/1991 | US5019501 Process for the activation of promoters of bacteria |
05/28/1991 | US5019500 IGF-I fusion proteins; protection of IGF-I from degradation by host cell proteases; and processes for the production thereof |
05/28/1991 | US5019499 Method of producing peptides by transforming myeloma cells with a recombinant plasmid |
05/28/1991 | CA2045483A1 Process for the preparation of vancomycin |
05/28/1991 | CA2030927A1 Fibrinolytic protein and production method thereof |
05/28/1991 | CA1284464C D(-)-mandelate dehydrogenase produced microbiologically, a process for its production and application thereof |
05/23/1991 | DE4007043A1 New restriction endonuclease RleAi from Rhizobium - recognising and cutting specific base sequence, useful in DNA analysis |
05/22/1991 | EP0428485A1 Novel antiidiotypic monoclonal antibodies |
05/22/1991 | EP0428286A2 24- and 25-substituted avermectin and milbemycin derivatives |
05/22/1991 | EP0428267A2 Erythropoietin isoforms |
05/22/1991 | EP0428141A2 Hybrid promoter |
05/22/1991 | EP0428061A1 Type II restriction endonuclease McrI |
05/22/1991 | EP0428060A1 Type II restriction endonuclease RleAI |
05/22/1991 | EP0427806A1 Fat hydrolysis process. |
05/22/1991 | EP0427771A1 Macrolactam antimicrobial compounds |
05/22/1991 | EP0237545B1 Production of pluripotent granulocyte colony-stimulating factor |
05/22/1991 | CN1051600A Dye transfer inhibition |
05/21/1991 | WO1991007425A1 Non-replicating recombinant-made retroviral particles used as antiviral agents and immunogens |
05/21/1991 | US5017603 Xanthomegnin, a known compound, is an antiparasitic agent |
05/21/1991 | US5017495 Biosynthesis of p-cresol |
05/21/1991 | US5017493 Ribosmoe binding site |
05/21/1991 | US5017487 Genetic engineering |
05/21/1991 | US5017482 Process for producing L-arginine |
05/21/1991 | US5017481 Biosynthesis |
05/21/1991 | US5017479 Enzymatic hydrolysis |
05/21/1991 | US5017388 Process for the preparation of vanillin |
05/21/1991 | CA2068713A1 Non-replicating recombinant-made retroviral particles used as antiviral agents and immunogens |
05/18/1991 | WO1991007500A1 Specific binding agents |
05/18/1991 | WO1991007490A1 Protein complexes having factor viii:c activity and production thereof |
05/18/1991 | WO1991007481A1 Mutants or variants of bacillus thuringiensis producing high yields of delta endotoxin |
05/18/1991 | CA2135744A1 Protein complexes having factor viii:c activity and production thereof |
05/18/1991 | CA2068728A1 Protein complexes having factor viii:c activity and production thereof |
05/18/1991 | CA2066670A1 Specific binding agents |
05/16/1991 | WO1991006866A2 Urinary tumor associated antigen, antigenic subunits uses and methods of detection |
05/16/1991 | WO1991006861A1 Immunoassays for and monoclonal antibodies to prothrombin activation peptides and their degradation products |
05/16/1991 | WO1991006667A1 Production of proteins using homologous recombination |
05/16/1991 | WO1991006666A1 Production of proteins using homologous recombination |
05/16/1991 | WO1991006663A1 Process for preparing ganglioside g¿m1? |
05/16/1991 | WO1991006662A1 Process for preparing asialo g¿m1? |
05/16/1991 | WO1991006660A1 Site-specific modification of the candida tropicalis genome |
05/16/1991 | WO1991006658A2 Infective protein delivery system |
05/16/1991 | WO1991006656A1 Promoter, expression vector and polypeptide synthesis |
05/16/1991 | WO1991006655A1 E. coli secretory strains |
05/16/1991 | WO1991006654A1 A method of vaccine or toxoid preparation and immunization by colonization with recombinant microorganisms |
05/16/1991 | WO1991006653A1 Recombinant vaccine for porcine pleuropneumonia |
05/16/1991 | WO1991006648A1 Glutamate receptor compositions and methods |
05/16/1991 | WO1991006632A1 Inhibition of padgem-mediated cell binding |
05/16/1991 | WO1991006574A1 A process for preparing peroxycarboxylic acids |
05/16/1991 | WO1991006571A1 A human t cell reactive feline protein (trfp) isolated from house dust and uses therefor |
05/16/1991 | WO1991006568A1 High molecular weight human angiogenic factors |
05/16/1991 | WO1991006566A1 Novel compounds |
05/16/1991 | WO1991006552A1 A83543 recovery process |
05/16/1991 | WO1991006319A1 Methods and compositions for promoting immunopotentiation |
05/16/1991 | WO1990013634A3 Enzymes and their use in drug detection |
05/16/1991 | WO1990012879A3 Expression of human apolipoproteins ai-milano in yeast |
05/16/1991 | CA2072977A1 Site-specific modification of the candida tropicalis genome |
05/16/1991 | CA2072657A1 Method of vaccine or toxoid preparation and immunization by colonization with recombinant microorganisms |
05/16/1991 | CA2071478A1 Methods and compositions for promoting immunopotentiation |
05/15/1991 | EP0427680A1 Heteroatoms-containing tricyclic compounds |
05/15/1991 | EP0427462A1 Process |
05/15/1991 | EP0427405A1 Yeasts and their use in astaxanthin production |
05/15/1991 | EP0427399A1 Cancer marker and monoclonal antibodies specific therefor |
05/15/1991 | EP0427385A1 Gene expression unit comprising the promoter and the terminator as well as the gene of alkaline protease |
05/15/1991 | EP0427296A1 Insulin precursors |
05/15/1991 | EP0427189A1 Modified forms of human erythropoietin and DNA sequences encoding genes which can express them |
05/15/1991 | EP0427142A1 Antibiotic A/16686 recovery process |
05/15/1991 | EP0427035A1 Protein overexpression in recombinant host cells |
05/15/1991 | EP0427014A1 Plasmid |
05/15/1991 | EP0426787A1 POLYPEPTIDE RESULTING FROM THE FUSION BETWEEN A MALTOSE-RELATED COMPOUND (MalE) AND A CD4 FRAGMENT FOR NEUTRALIZING THE AIDS VIRUS |
05/15/1991 | EP0426744A1 High efficiency translation of polycistronic messages in eucaryotic cells |
05/15/1991 | CN1051393A Cytokine synthesis inhibitory factor, antagonists thereof and methods of using same |
05/15/1991 | CN1051389A Novel antibodies reactive with human carcinomas |
05/15/1991 | CN1051302A Biologically active proteins and method for their prodn. |
05/15/1991 | CA2029714A1 Antiidiotypic monoclonal antibodies |
05/14/1991 | WO1991007664A1 Diagnostic proteins to test for more than one antibody |
05/14/1991 | WO1991007494A1 Chimeric mouse human antibodies with specificity to hiv antigens |
05/14/1991 | WO1991007482A1 Type-b rotavirus cultures and uses thereof |
05/14/1991 | WO1991007418A1 Chimeric mouse-human a10 antibody with specificity to a human tumor cell antigen |
05/14/1991 | US5015662 Anthelmintic bioconversion products |
05/14/1991 | US5015581 Method for producing the Hinc II restriction endonuclease and methylase |
05/14/1991 | US5015579 Production of (-)trans-2,3-epoxysuccinic acid by fermentation |
05/14/1991 | US5015578 BMY-41950 antitumor antibiotic |
05/14/1991 | US5015574 Genetic engineering |